Clinical Research & Trials Center
in Metairie, Louisiana

Studies We Offer

Liver disease

Fatty Liver Disease – Metarie

Condition: Fatty Liver Disease (NASH)
Diabetic neuropathy handwritten on a blackboard.

Diabetic Peripheral Neuropathy – Metairie

Condition: DPN

Our Doctors

Dr fatakia

Adil Fatakia

MD, MBA, CMO

Adil Fatakia, MD, MBA, CMO, oversees the effective management of patient care in all of Tandem’s clinics in addition to being Principal Investigator and Sub-Investigator on more than 150+ gastrointestinal trials. A native of New Orleans, he realized the “niche” of fatty liver disease studies in Louisiana and the treatment it lacked. Dr. Fatakia is Tandem’s best recruitment specialist, growing the networking database with new physicians and trial participants daily. He earned his medical and business degrees from Tulane University. He is certified in otolaryngology-head and neck surgery by the American Board of Otolaryngology.

Dr reiss

Gary Reiss

MD, MBA, MPH, Medical Director

Gary Reiss, MD, MBA, MPH, Medical Director, is a board-certified gastroenterologist and a member of several GI societies, including the American College of Gastroenterology. He is well-published in a variety of professional journals and has been featured in the “Best Doctors” issue of New Orleans Magazine. Dr. Reiss holds the position of Medical Director in addition to serving as Principal Investigator and Sub-Investigator on a number of studies. He has performed more than 1,500+ liver biopsies and has also contributed to the enrollment of 250+ NASH/NALFD participants from his private practice’s database.

Metairie Office

Tandem Clinical Research’s Metairie clinic is located in a free-standing three-story building in the heart of Metairie, Louisiana.

See If You Qualify









Professional-women-pointing-form

What People Are Saying About Us Online

Lorem ipsum dolor sit amet, consectetur adipiscing elit. Ut elit tellus, luctus nec ullamcorper mattis, pulvinar dapibus leo.
Lisa Brown
Designer
Lorem ipsum dolor sit amet, consectetur adipiscing elit. Ut elit tellus, luctus nec ullamcorper mattis, pulvinar dapibus leo.
Blaine lyman
Investor